Industry: Biomedicine Region: Denmark Transaction Price: USD 1 million Transaction Method: Equity Investment
Project introduction:
Denmark is a biopharmaceutical company, focusing on helping to solve the unmet medical needs of patients with serious diseases, and discovering, developing and providing new drugs to help patients overcome serious diseases.
The company has a broad patient resource base, including immune diseases, cancer and other diseases, to develop drugs, while paying attention to the prognosis of drugs.
In addition, risk assess ment and mitigation strategies (REMS) are provided to manage known or potential serious risks related to drugs, and to enable patients to obtain such drugs by managing their safe use, so as to prevent some serious risks related to taking such drugs.
Cooperation mode:
Looking for partners who are interested in this technology to jointly promote cooperation in various forms such as distribution agency and technical cooperation.